ABBVNYSELive delayed
$256.91
-2.45-0.94%
SourceCNBCAs ofJul 27, 2026, 8:10 PM
Delayed market data from CNBC. Not investment advice.
AbbVie is a healthcare name tracked on StockWatch with delayed quotes, charts, and related news. Home market: United States.
Key statistics
Delayed fundamentals for ABBV · Finnhub.
- Market cap
- $458.24B
- P/E (TTM)
- 108.43
- EPS (TTM)
- $2.0489
- Div. yield
- 2.67%
- 52-week range
- $187.62 – $261.635
- Volume
- —
- Avg volume
- 5.21M
Price history
OHLC candles for ABBV · 3mo · 1d · Yahoo Finance · delayed · EMA / RSI
+29.96%periodDirect mentions, stories that impact this name, and related market themes — with Impact Analysis on each headline.
DirectHigh impactGlobalMostly neutralGoogle News
The Engine Behind ABBV Stock Has Real PartsThe Engine Behind ABBV Stock Has Real Parts TrefisBroad market headline — check whether risk appetite shifts.
Watch: ABBV · .SPX · .FTSE · .N225
DirectHigh impactGoogle News
AbbVie (ABBV) Stock May Trade Above Fair Value Following Its 157% RunDirectHigh impactGoogle News
Earnings week ahead: AAPL. MSFT, AMZN, META, XOM, PYPL, CVX, F, KO, ABBV, V, QCOM, BA, MO, SOFI, and moreDirectHigh impactGoogle News
AbbVie (ABBV) Q1 2026 Earnings Call TranscriptDirectHigh impactGoogle News
AbbVie (ABBV) Misses Key Phase 3 Survival Goal For Epcoritamab In DLBCLDirectHigh impactGoogle News
AbbVie: A Dividend Fortress At An Appealing Price TagDirectHigh impactGoogle News
AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseDirectHigh impactGoogle News
3 Reasons to Buy AbbVie Stock Like There's No Tomorrow